Mutations in BSCL2, which encodes the protein seipin, and AGPAT2, which encodes lysophosphatidic acid acyltransferase B, lead to biochemical disruptions such as hypertriglyceridemia, hypoadiponectemia, and hyperglycemia [4,5]. The gene discussed is BSCL2; the disease is Hyperglycemia.